149 related articles for article (PubMed ID: 32914670)
1. Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome.
Steinhardt MJ; Wiebecke S; Weismann D; Frantz S; Tony HP; Klinker H; Schmalzing M
Scand J Rheumatol; 2020 Sep; 49(5):414-416. PubMed ID: 32914670
[No Abstract] [Full Text] [Related]
2. Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?
Bilia S; Giannini D; Rizzelli GML; Tavoni A
Clin Exp Rheumatol; 2020; 38(3):579. PubMed ID: 32456767
[No Abstract] [Full Text] [Related]
3. Cytokine storm and the prospects for immunotherapy with COVID-19.
Calabrese LH
Cleve Clin J Med; 2020 Jun; 87(7):389-393. PubMed ID: 32393592
[TBL] [Abstract][Full Text] [Related]
4. Is a "Cytokine Storm" Relevant to COVID-19?
Sinha P; Matthay MA; Calfee CS
JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883
[No Abstract] [Full Text] [Related]
5. Successful use of methylprednisolone for treating severe COVID-19.
Liu J; Zheng X; Huang Y; Shan H; Huang J
J Allergy Clin Immunol; 2020 Aug; 146(2):325-327. PubMed ID: 32479759
[No Abstract] [Full Text] [Related]
6. Cytokine release syndrome in severe COVID-19.
Moore JB; June CH
Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
[No Abstract] [Full Text] [Related]
7. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
8. Ventilatory Ratio in Hypercapnic Mechanically Ventilated Patients with COVID-19-associated Acute Respiratory Distress Syndrome.
Liu X; Liu X; Xu Y; Xu Z; Huang Y; Chen S; Li S; Liu D; Lin Z; Li Y
Am J Respir Crit Care Med; 2020 May; 201(10):1297-1299. PubMed ID: 32203672
[No Abstract] [Full Text] [Related]
9. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment.
O'Driscoll L
Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262
[No Abstract] [Full Text] [Related]
10. Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients.
Despres C; Brunin Y; Berthier F; Pili-Floury S; Besch G
Crit Care; 2020 May; 24(1):256. PubMed ID: 32456663
[No Abstract] [Full Text] [Related]
11. On the Alert for Cytokine Storm: Immunopathology in COVID-19.
Henderson LA; Canna SW; Schulert GS; Volpi S; Lee PY; Kernan KF; Caricchio R; Mahmud S; Hazen MM; Halyabar O; Hoyt KJ; Han J; Grom AA; Gattorno M; Ravelli A; De Benedetti F; Behrens EM; Cron RQ; Nigrovic PA
Arthritis Rheumatol; 2020 Jul; 72(7):1059-1063. PubMed ID: 32293098
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and rheumatology: is shielding really necessary?
Amani L; Warraich R; Patel N; Tahir H
Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589537
[TBL] [Abstract][Full Text] [Related]
13. A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Cai S; Sun W; Li M; Dong L
Clin Rheumatol; 2020 Sep; 39(9):2797-2802. PubMed ID: 32562070
[TBL] [Abstract][Full Text] [Related]
14. Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.
Aouba A; Baldolli A; Geffray L; Verdon R; Bergot E; Martin-Silva N; Justet A
Ann Rheum Dis; 2020 Oct; 79(10):1381-1382. PubMed ID: 32376597
[No Abstract] [Full Text] [Related]
15. Air Hunger and Psychological Trauma in Ventilated Patients with COVID-19. An Urgent Problem.
Worsham CM; Banzett RB; Schwartzstein RM
Ann Am Thorac Soc; 2020 Aug; 17(8):926-927. PubMed ID: 32501114
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease.
Pontali E; Volpi S; Antonucci G; Castellaneta M; Buzzi D; Tricerri F; Angelelli A; Caorsi R; Feasi M; Calautti F; Castagnola E; Rollandi GA; Ravelli A; Cassola G; Gattorno M
J Allergy Clin Immunol; 2020 Jul; 146(1):213-215. PubMed ID: 32437739
[No Abstract] [Full Text] [Related]
17. Interleukin-6 levels in children developing SARS-CoV-2 infection.
Soraya GV; Ulhaq ZS
Pediatr Neonatol; 2020 Jun; 61(3):253-254. PubMed ID: 32414693
[No Abstract] [Full Text] [Related]
18. Cerebral venous thrombosis in patients with severe COVID-19 infection in intensive care.
Keaney K; Mumtaz T
Br J Hosp Med (Lond); 2020 Sep; 81(9):1-4. PubMed ID: 32990081
[No Abstract] [Full Text] [Related]
19. Acute Cerebellar Strokes with Anoxic Brain Injury After a Cardiopulmonary Arrest in SARS-CoV-2 Patient.
Janjua T; Moscote-Salazar LR
Acta Med Indones; 2020 Apr; 52(2):177-178. PubMed ID: 32778633
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression drug advice and COVID-19: are we doing more harm than good?
Warraich R; Amani L; Mediwake R; Tahir H
Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
